Novartis is a healthcare company which strives to change the practice of medicine and aspires to approach things differently. We are passionate about what we do and the impact we have on patients and societies. We are Novartis, and we are re-imagining medicine.
Our company comprises three unique divisions: Innovative Medicines, Sandoz and Alcon
At Novartis we are re-imagining medicine in terms of how we fight disease, deliver treatments to patients and operate as a company. We work to improve healthcare in the UK through our visionary thinking and science-based innovation.
Our specialist business units, Novartis Oncology and Novartis Pharmaceuticals, form our Innovative Medicines Division. Our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to deliver better patient outcomes and help achieve our mission.
Generics and Biosimilars
Sandoz is the generic pharmaceutical division of Novartis and has a long history of providing high quality, affordable products to the NHS. The company is a global leader in generic medicines and biosimilars and strives to discover new ways to improve and extend lives.
Alcon is a leader in ophthalmology care in the UK and specialises in contact lens products and surgical devices. Alcon has one mission: to discover new ways to enhance sight and improve people's lives.